Nancy Hunter

Nancy Hunter is an accomplished professional with a strong background in Strategy and Portfolio management, People development, and international leadership as a member of the EMEA Management Team.

She has successfully led numerous market launches in both the US and EMEA regions, specifically in rare disease and oncology, including immunotherapy, breast, prostate, and lung cancer treatments.

With her recent experience focused on two EU start-ups in Zug, Switzerland, Nancy has honed her expertise across various global, US, and European roles, demonstrating a versatile skill set.

Nancy's specialties include bringing new pharmaceutical products to market in the US and EU, market opportunity assessment, building new functional verticals in start-up environments, leading diverse cross-functional teams, commercial strategy development, launch preparation, budget and operations management, brand planning, and OPEX management.

Her educational background includes an MBA from Pepperdine Graziadio Business School, a BA from Concordia College, and an ABS from Trinity Lutheran College, providing her with a well-rounded foundation for her professional achievements.

Currently, Nancy Hunter serves as the Head of Commercial at bluebird bio, showcasing her expertise and leadership in the pharmaceutical industry.